FrancophonIA/ELRC3.0 huggingface dataset:
English: The active substance in Zytiga, abiraterone acetate, is changed in the body to abiraterone which stops the body producing testosterone, a male hormone.
Slovenian: Zdravilna učinkovina v zdravilu Zytiga, abirateron acetat, se v telesu pretvori v abirateron, ki zavre proizvodnjo moškega hormona testosterona.
English: One study involved 1,209 patients with newly diagnosed, high-risk, hormone-sensitive, metastatic prostate cancer.
Slovenian: Ena študija je zajemala 1 209 bolnikov z novo ugotovljenim metastatskim rakom na prostati z visokim tveganjem in občutljivim na hormone.
English: Zytiga is well tolerated and its risks are considered manageable.
Slovenian: Bolniki zdravilo Zytiga dobro prenašajo, z njim povezana tveganja pa so obvladljiva.
English: For the full list of all side effects reported with Zytiga, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Zytiga, glejte navodilo za uporabo.
English: How does Zytiga work?
Slovenian: Kako zdravilo Zytiga deluje?
English: Patients treated with Zytiga lived for just under 15 months from the start of treatment compared with just under 11 months for patients given placebo.
Slovenian: Bolniki, ki so prejemali zdravilo Zytiga so po začetku zdravljenja živeli nekaj manj kot 15 mesecev, medtem ko so bolniki, ki so prejemali placebo, živeli nekaj manj kot 11 mesecev.
English: Patients treated with Zytiga lived for an average of around 16 months without their disease getting worse, compared with around 8 months in patients given placebo.
Slovenian: Bolniki, ki so prejemali zdravilo Zytiga, so v povprečju živeli okoli 16 mesecev brez poslabšanja bolezni, medtem ko je bilo pri bolnikih, ki so prejemali placebo, to obdobje dolgo okoli 8 mesecev.
English: How is Zytiga used?
Slovenian: Kako se zdravilo Zytiga uporablja?
English: Zytiga contains the active substance abiraterone acetate.
Slovenian: Zdravilo Zytiga vsebuje zdravilno učinkovino abirateron acetat.
English: Patients treated with Zytiga lived for an average of 33 months without their disease getting worse, compared with around 15 months for patients given placebo.
Slovenian: Bolniki, ki so prejemali zdravilo Zytiga, so v povprečju živeli 33 mesecev brez poslabšanja bolezni, medtem ko je bilo pri bolnikih, ki so prejemali placebo, to obdobje dolgo okoli 15 mesecev.
English: Adopted at the 28-31 October 2019 PRAC
Slovenian: Sprejeto na seji odbora PRAC med 28. in 31. oktobrom 2019
English: Tell your doctor immediately if you experience any of the following signs and symptoms that may indicate a serious allergic reaction ………….
Slovenian: Nemudoma obvestite zdravnika, če opazite katerega koli od naslednjih znakov in simptomov, ki lahko kažejo na resno alergijsko reakcijo ………….
English: Frequency ‘Not known': Kounis syndrome
Slovenian: Neznana pogostnost: Kounisov sindrom
English: There have been reports of hypersensitivity reactions which progressed to Kounis syndrome (acute allergic coronary arteriospasm that can result in myocardial infarction, see section 4.8).
Slovenian: Poročali so o preobčutljivostnih reakcijah, ki so napredovale do Kounisovega sindroma (akutnega alergijskega koronarnega arteriospazma, ki lahko privede do miokardnega infarkta, glejte poglavje 4.8).
English: And chest pain which can be a sign of a potentially serious allergic reaction called Kounis syndrome.
Slovenian: in bolečina v prsnem košu, ki je lahko znak potencialno resne alergijske reakcije, imenovane Kounisov sindrom.
English: Iron sucrose; iron carboxymaltose; iron isomaltoside; iron dextran; sodium ferric gluconate - Arteriospasm coronary (EPITT no 19408)
Slovenian: Železov saharat, železova karboksimaltoza, železov izomaltozid, železov dekstran, natrijev železov glukonatkoronarni arteriospazem (št. EPITT 19408)
English: New product information wording - Extracts from PRAC recommendations on signals EMA/PRAC/580133/2019
Slovenian: Novo besedilo informacij o zdravilu - izvlečki iz priporočil odbora PRAC o signalih EMA/PRAC/601866/2019
English: Hypersensitivity reactions have also been reported after previously uneventful doses of parenteral iron complexes.
Slovenian: O preobčutljivostnih reakcijah so poročali tudi po odmerkih parenteralnih kompleksov železa, pri katerih prej ni bilo reakcij.
English: Parenterally administered iron preparations can cause hypersensitivity reactions including serious and potentially fatal anaphylactic/anaphylactoid reactions.
Slovenian: Parenteralno dana zdravila, ki vsebujejo železo, lahko povzročijo preobčutljivostne reakcije, vključno s hudimi anafilaktičnimi/anafilaktoidnimi reakcijami, ki so lahko smrtne.
English: Undesirable effetcs Cardiac disorders
Slovenian: Srčne bolezni
English: The procedure started on 24 May 2007.
Slovenian: Postopek se je začel dne 24. maja 2007.
English: Ref. EMEA/CHMP/384875/2008
Slovenian: EMEA/CHMP/674034/2008
English: A Decision was issued by the European Commission on 28 November 2008.
Slovenian: Evropska komisija je odločbo izdala 28. novembra 2008.
English: The Marketing Authorisation Holder provided supplementary information on 26 September 2007.
Slovenian: Imetnik dovoljenja za promet z zdravilom je dne 26. septembra 2007 priskrbel dodatne informacije.
English: London, 02 December 2008 Doc.
Slovenian: London, 2.decembra 2008 Sklic na dok.
English: Efexor, 25 mg, 37.5 mg, 50 mg, 75 mg, tablets, is an antidepressant indicated for the treatment of major depressive episodes and for the prevention of recurrence of major depressive episodes.
Slovenian: Zdravilo Efexor, 25 mg, 37,5 mg, 50 mg, 75 mg, je antidepresiv, namenjen za zdravljenje hudih epizod depresije in za preprečevanje njihovega ponovnega pojava.
English: COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) OPINION FOLLOWING AN ARTICLE 30 REFERRAL FOR Efexor and associated names International Non-Proprietary Name (INN): venlafaxine
Slovenian: ODBOR ZA ZDRAVILA ZA UPORABO V HUMANI MEDICINI (CHMP) MNENJE V ZVEZI Z NAPOTITVIJO V SKLADU S ČLENOM 30 ZA ZDRAVILO Efexor in z njim povezana imena Mednarodno nelastniško ime (INN): venlafaksin
English: The basis for referral was that there were divergences in the Summaries of Product Characteristics (SPC) of Efexor approved across EU Member States, with respect to the treatment of major depressive episodes and for the prevention of recurrence of major depressive episodes.
Slovenian: Podlaga za napotitev so bila razhajanja med povzetki glavnih značilnosti zdravila (SPC) Efexor, ki so bili odobreni v državah članicah EU v zvezi z zdravljenjem hudih epizod depresije in preprečevanjem njihovega ponovnega pojava.
English: The CHMP gave a positive opinion on 24 July 2008 with a subsequent revision on 25 September 2008 recommending the harmonisation of the SPC, Labelling and Package Leaflet for Efexor.
Slovenian: CHMP je dne 24. julija 2008 izdal pozitivno mnenje, temu pa je dne 25. septembra 2008 sledila revizija, na podlagi katere se priporoča 2008 uskladitev povzetkov glavnih značilnosti zdravila (SPC), označevanj in navodil za uporabo zdravila Efexor.
English: The list of product names concerned is given in Annex I. The scientific conclusions are provided in Annex II together with the amended SPC, Labelling and Package Leaflet in Annex III.
Slovenian: Seznam zadevnih imen zdravil je naveden v Dodatku I. Znanstveni zaključki so na voljo v Dodatku II, spremenjeni povzetki glavnih značilnosti zdravila, označevanje in navodilo za uporabo pa v Dodatku III.
English: During its July 2008 meeting, the CHMP, in the light of the overall submitted data and the scientific discussion within the Committee, was of the opinion that the proposal for the harmonisation of the SPC, Labelling and Package Leaflet was acceptable and that they should be amended.
Slovenian: Med svojim zasedanjem julija 2008 je CHMP na osnovi vseh predloženih podatkov in znanstvene razprave v Odboru menil, da je predlog za uskladitev povzetkov glavnih značilnosti zdravila, označevanja in navodila za uporabo sprejemljiv in da bi bilo treba navedene dokumente dopolniti.
English: This medicinal product belongs to the 2007 list of products identified for SPC harmonisation.
Slovenian: Zdravilo spada na seznam zdravil iz leta 2007, katerih povzetke glavnih značilnosti zdravila je treba uskladiti.
English: On 3 May 2007, the European Commission presented to the EMEA a referral under Article 30 of Directive 2001/83/EC, as amended, in order to harmonise the nationally authorised Summaries of Product Characteristics (SPC), Labelling and Package Leaflet of the medicinal product Efexor.
Slovenian: Direktive 2001/83/ES, kakor je bila spremenjena, da bi uskladila na nacionalni ravni odobrene povzetke glavnih značilnosti zdravila (SPC), označevanja in navodila za uporabo zdravila Efexor.
English: The following definitions of frequencies are used:
Slovenian: Uporabljene so naslednje definicije pogostnosti:
English: France: Flodil
Slovenian: Francija: Flodil
English: (see section 4.5).
Slovenian: (glejte poglavji 5.1 in 5.2).
English: Caution is recommended especially at the start of treatment.
Slovenian: Previdnost je priporočljiva zlasti na začetku zdravljenja.
English: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain, Sweden, United Kingdom: Plendil
Slovenian: Islandija, Irska, Italija, Latvija, Litva, Luksemburg, Malta, Nizozemska, Norveška, Poljska, Portugalska, Romunija, Slovaška, Španija, Švedska, Velika Britanija: Plendil
English: The product information may be subsequently updated by the Member State competent authorities, in liaison with the Reference Member State, as appropriate, in accordance with the procedures laid down in Chapter 4 of Title III of Directive 2001/83/EC.
Slovenian: Informacije o zdravilu se lahko naknadno posodobijo s strani regulatornega organa države članice v povezavi z referenčno državo članico, kot je primerno v skladu s postopki opisanimi v poglavju 4 pod naslovom III Direktive 2001/83/ES.
English: • Skin reactions due to increased sensitivity to sunlight
Slovenian: • kožne reakcije zaradi večje občutljivosti za sončno svetlobo
English: The long-term effects of felodipine on growth, puberty and general development have not been studied.
Slovenian: Dolgoročnih učinkov felodipina na rast, puberteto in splošni razvoj niso raziskali.
English: Therefore, it is very important that you take the number of doses prescribed by your doctor.
Slovenian: Zato je zelo pomembno, da jemljete takšen odmerek, kot vam ga je predpisal zdravnik.
English: {Name and Address} {tel} {fax} {e-mail}
Slovenian: {Ime in naslov} {tel.} {faks} {e-pošta}
English: Your doctor will advise you how long to take your medicine.
Slovenian: Zdravnik vam bo povedal, kako dolgo morate jemati zdravilo.
English: The enlargement can be avoided or reversed by careful oral hygiene.
Slovenian: Takšno povečanje je mogoče preprečiti ali odpraviti s skrbno ustno higieno.
English: Plendil with food and drink
Slovenian: Zdravilo Plendil skupaj s hrano in pijačo
English: This Summary of Product Characteristics, labelling and package leaflet is the outcome of the referral procedure to which this Commission decision relates.
Slovenian: Ta Povzetek glavnih značilnosti zdravila, označevanje in navodilo za uporabo je rezultat postopka napotitve, na katerega se navezuje ta odločba Evropske komisije.
English: Germany: Modip Italy: Feloday, Prevex Portugal: Preslow Sweden: Felodipin AstraZeneca
Slovenian: Italija: Feloday, Prevex Portugalska: Preslow Švedska: Felodipin AstraZeneca
English: Very rare < 1/10,000
Slovenian: zelo redki < 1/10.000
English: If severe hypotension occurs, symptomatic treatment should be instituted.
Slovenian: Če se pojavi huda hipotenzija, je treba uvesti simptomatsko zdravljenje.
English: Do not use this medicine if you notice the packaging is torn or damaged.
Slovenian: Ne uporabite tega zdravila, če je pakiranje pretrgano ali poškodovano.
English: Your doctor may lower the dose.
Slovenian: Zdravnik vam lahko zmanjša odmerek.
English: If necessary, your doctor may increase the dose or add another blood-pressure lowering medicine.
Slovenian: Če je potrebno, vam zdravnik lahko poveča odmerek ali doda kakšno drugo zdravilo za znižanje krvnega tlaka.
English: Felodipine should not be given during pregnancy.
Slovenian: Felodipina se ne sme uporabljati med nosečnostjo.
English: The tablets should be taken in the morning and be swallowed with water.
Slovenian: Tablete je treba vzeti zjutraj in jih zaužiti z vodo.
English: If you experience these symptoms, seek emergency care immediately.
Slovenian: Če začutite ta dva simptoma, takoj poiščite nujno zdravniško pomoč.
English: Additional interactions
Slovenian: Dodatna medsebojna delovanja
English: Volume of distribution at steady state is 10 L/kg.
Slovenian: Volumen porazdelitve v stanju dinamičnega ravnovesja je 10 l/kg.
English: The half-life of felodipine in the elimination phase is approximately 25 hours and steady state is reached after 5 days.
Slovenian: Razpolovni čas felodipina v fazi izločanja je približno 25 ur in stanje dinamičnega ravnovesja je doseženo po 5 dneh.
English: This results from precapillary vasodilatation and is not related to any generalised fluid retention.
Slovenian: To je posledica predkapilarne vazodilatacije in ni povezano s kakšnim generaliziranim zastajanjem tekočine.
English: Generally, a reduction in blood pressure is evident two hours after the first oral dose and lasts for at least 24 hours and the trough/peak ratio is usually well above 50%.
Slovenian: Na splošno je znižanje krvnega tlaka opazno dve uri po prvem peroralnem odmerku in traja vsaj 24 ur; razmerje med dnom in vrhom je po navadi precej nad 50 %.
English: Other undesirable effects may occur.
Slovenian: Pojavijo se lahko še drugi neželeni učinki.
English: Uncommon ≥ 1/1,000 to < 1/100 Rare ≥ 1/10,000 to < 1/1,000
Slovenian: zelo pogosti ≥ 1/10 pogosti ≥ 1/100 do < 1/10 občasni ≥ 1/1.000 do < 1/100 redki ≥ 1/10.000 do < 1/1,000
English: If necessary another antihypertensive agent may be added.
Slovenian: Če je treba, je mogoče dodati še drugo antihipertenzivno zdravilo.
English: Examples are:
Slovenian: Primeri so:
English: Other medicines and Plendil
Slovenian: Druga zdravila in zdravilo Plendil
English: The study failed to demonstrate the efficacy of felodipine in lowering blood pressure in children aged 6-16 years (see section 4.2)
Slovenian: Študija ni dokazala učinkovitosti felodipina za znižanje krvnega tlaka pri otrocih v starosti od 6 do 16 let (glejte poglavje 4.2).
English: What Plendil is and what it is used for
Slovenian: Kaj je zdravilo Plendil in za kaj ga uporabljamo
English: About 70% of a given dose is excreted as metabolites in the urine; the remaining fraction is excreted in the faeces.
Slovenian: Približno 70 % uporabljenega odmerka se v obliki presnovkov izloči v urinu; preostali del se izloči v blatu.
English: Most of these reactions appear at start of treatment or after a dose increase.
Slovenian: Večina teh učinkov se pojavi na začetku zdravljenja ali po povečanju odmerka.
English: Less than 0.5% of a dose is recovered unchanged in urine.
Slovenian: 0,5 % odmerka se nespremenjenega pojavi v urinu.
English: These effects are dose-dependent.
Slovenian: Ti učinki so odvisni od odmerka.
English: The study showed benefits of lowering SBP and DBP down to 139 and 83 mmHg, respectively.
Slovenian: Študija je pokazala koristi znižanja SKT na 139 in DKT na 83 mmHg.
English: The efficacy and safety of felodipine in the treatment of hypertensive emergencies has not been studied.
Slovenian: Učinkovitosti in varnosti felodipina pri zdravljenju nujnih hipertenzivnih stanj niso raziskali.
English: Enzyme interactions
Slovenian: Encimske interakcije
English: Management If justified: activated charcoal, gastric lavage if performed within one hour after ingestion.
Slovenian: Če je upravičeno: aktivno oglje; izpiranje želodca, če je opravljeno v eni uri po zaužitju.
English: The plasma protein binding of felodipine is approximately 99%.
Slovenian: Porazdelitev Vezava felodipina na beljakovine v plazmi je približno 99 %.
English: The relevance of these findings for patients receiving felopidine is unknown.
Slovenian: Pomen teh izsledkov za bolnike, ki dobivajo felodipin, ni znan.
English: Elderly patients and patients with reduced liver function have on average higher plasma concentrations of felodipine than younger patients.
Slovenian: Starejši bolniki in bolniki z zmanjšanim delovanjem jeter imajo v povprečju višjo koncentracijo felodipina v plazmi kot mlajši bolniki.
English: A total of 18,790 hypertensive patients (DBP 100-115 mmHg), aged 50-80 years were followed for a mean period of 3.8 years (range 3.3-4.9).
Slovenian: Skupno 18.790 hipertenzivnih bolnikov (DKT 100-115 mmHg), starih od 50 do 80 let, so spremljali povprečno 3,8 let (razpon: od 3,3 do 4,9).
English: If you stop taking this medicine your condition may return.
Slovenian: Če prenehate jemati to zdravilo, se vaše težave lahko ponovijo.
English: Felodipine is a high clearance medicinal product with an average blood clearance of 1200 ml/min.
Slovenian: Felodipin je zdravilo z velikim očistkom; povprečni očistek iz krvi je 1200 ml/min.
English: The long-term efficacy of antihypertensive therapy as therapy in childhood to reduce cardiovascular morbidity and mortality in adulthood has also not been established.
Slovenian: Prav tako ni ugotovljena dolgoročna učinkovitost antihipertenzivnega zdravljenja v otroških letih za zmanjšanje kardiovaskularne obolevnosti in umrljivosti v odrasli dobi.
English: What Plendil is and what it is used for What you need to know before you take Plendil How to take Plendil
Slovenian: Kaj je zdravilo Plendil in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Plendil Kako jemati zdravilo Plendil
English: Plendil contains lactose that is a type of sugar.
Slovenian: Zdravilo Plendil vsebuje laktozo, ki je vrsta sladkorja.
English: Most of these adverse reactions are dose-dependent and appear at the start of treatment or after a dose increase.
Slovenian: Večina teh neželenih učinkov je odvisnih od odmerka in se pojavijo na začetku zdravljenja ali po povečanju odmerka.
English: • Cimetidine
Slovenian: • cimetidin
English: Overdosage may cause excessive peripheral vasodilatation with marked hypotension and sometimes bradycardia.
Slovenian: Preveliko odmerjanje lahko povzroči prekomerno periferno vazodilatacijo z izrazito hipotenzijo in včasih bradikardijo.
English: Should such adverse reactions occur, they are usually transient and diminish with time.
Slovenian: Če se pojavijo takšni neželeni učinki, so po navadi prehodni in se sčasoma zmanjšajo.
English: if you are allergic to felodipine or any of the other ingredients of this medicine (listed in section 6).
Slovenian: - če ste alergični na felodipin ali katero koli sestavino tega zdravila, navedeno v poglavju 6.
English: Medicines containing St John's wort (Hypericum perforatum) (herbal product used to treat depression) may reduce the effect of Plendil and should therefore be avoided.
Slovenian: Zdravila, ki vsebujejo šentjanževko (Hypericum perforatum) (pripravek rastlinskega izvora, ki se uporablja za zdravljenje depresije), lahko zmanjšajo učinek zdravila Plendil in se jim je zato treba izogibati.
English: The patient should be placed supine with the legs elevated.
Slovenian: Bolnika je treba poleči in mu dvigniti noge.
English: DATE OF REVISION OF THE TEXT <{MM/YYYY}> <{DD/MM/YYYY}> <{DD month YYYY}> [To be completed nationally]
Slovenian: DATUM ZADNJE REVIZIJE BESEDILA <{MM. LLLL}> <{DD/MM/LLLL}> <{DD. mesec LLLL}>
English: This leaflet was last revised in {MM/YYYY} {month YYYY}
Slovenian: Navodilo je bilo nazadnje revidirano dne {MM. LLLL} {mesec LLLL}
English: Maximum blood plasma levels (tmax) are achieved with the prolonged-release form after 3 to 5 hours.
Slovenian: Največja koncentracija v krvi je med uporabo oblike s podaljšanim sproščanjem dosežena po 3 do 5 urah (tmax).
English: The dose should be adjusted individually.
Slovenian: Odmerek je treba prilagoditi posameznemu bolniku.
English: if you have acute myocardial infarction (heart attack).
Slovenian: - če imate akuten miokardni infarkt (srčno kap).
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION <Date of first authorisation: {DD month YYYY}> <Date of latest renewal: {DD month YYYY}>
Slovenian: <Datum prve odobritve: {DD. mesec LLLL}> <Datum zadnjega podaljšanja: {DD. mesec LLLL}>
English: • Hypersensitivity to felodipine or any of the excipients listed in section 6.1
Slovenian: • preobčutljivost na felodipin ali katero koli pomožno snov, navedeno v poglavju 6.1.
English: The systemic availability of felodipine is approximately 15% and is independent of dose in the therapeutic dose range.
Slovenian: Sistemska uporabnost felodipina je približno 15 % in v razponu terapevtskih odmerkov ni odvisna od odmerka.
English: • Hypersensitivity reactions such as fever or swelling of the lips and tongue
Slovenian: • preobčutljivostne reakcije, npr. zvišana telesna temperatura ali oteklost ustnic in jezika
English: • Increased liver enzymes
Slovenian: • zvišanje jetrnih encimov
English: In case of accompanying bradycardia, atropine 0.5-1 mg should be administered intravenously.
Slovenian: V primeru spremljajoče bradikardije je treba dati od 0,5 do 1 mg atropina intravensko.
English: Antihypertensive treatment with felodipine is associated with significant regression of pre-existing left ventricular hypertrophy.
Slovenian: Antihipertenzivno zdravljenje s felodipinom je povezano s pomembnim nazadovanjem pred tem prisotne hipertrofije levega prekata.
English: If any of the following happen to you, stop taking Plendil and tell a doctor straight away:
Slovenian: Če se vam pojavi kaj od naslednjega, nehajte jemati zdravilo Plendil in takoj obvestite zdravnika:
English: If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicine.
Slovenian: Če vam je zdravnik povedal, da ne prenašate mekaterih sladkorjev, se z njim posvetujte, preden vzamete to zdravilo.
English: It does not negatively affect the heart function.
Slovenian: Zdravilo nima neugodnega vpliva na delovanje srca.
English: PHARMACEUTICAL FORM AND CONTENTS 2.5 mg tablet
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA 2,5-mg tableta
English: The anomalies in the foetuses were induced when felodipine was administered during early foetal development (before day 15 of pregnancy).
Slovenian: Nepravilnosti pri plodovih so se pojavile, če je bil felodipin uporabljen med zgodnjim razvojem ploda (pred 15. dnem brejosti).
English: • barbiturates (medicine to treat anxiety, sleeping problems and epilepsy)
Slovenian: • barbiturati (zdravila za zdravljenje tesnobnosti, težav s spanjem in epilepsije)
English: If you have any further questions, ask your doctor.
Slovenian: - Če imate dodatna vprašanja, se posvetujte z zdravnikom.
English: When used together, the tacrolimus serum concentration should be followed and the tacrolimus dose may need to be adjusted.
Slovenian: Če sta uporabljena skupaj, je treba koncentracijo takrolimusa v serumu kontrolirati in potrebna je lahko prilagoditev odmerka takrolimusa.
English: Felodipine tablets should not be taken together with grapefruit juice.
Slovenian: Tablet s felodipinom se ne sme zaužiti skupaj z grenivkinim sokom.
English: • Barbiturates
Slovenian: • barbiturati
English: Please consult your doctor and seek advice before you stop taking Plendil.
Slovenian: Pogovorite in posvetujte se z zdravnikom, preden prenehate jemati zdravilo Plendil.
English: Practice good oral hygiene to help avoid your gums from swelling (see section 4).
Slovenian: Skrbite za dobro ustno higieno, da boste preprečili otekanje dlesni (glejte poglavje 4).
English: Children The use of Plendil is not recommended in children.
Slovenian: Zdravila Plendil ni priporočljivo uporabljati pri otrocih.
English: If this is not sufficient, plasma volume should be increased by infusion of e.g., glucose, saline, or dextran.
Slovenian: Če to ne zadošča, je treba povečati volumen plazme z infuzijo, npr. z infuzijo glukoze, fiziološke raztopine ali dekstrana.